FDA
approval
· 2018-02-07
FDA Approved: BIKTARVY — Original Application (Gilead Sciences, Inc.)
Summary
FDA approved Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) as a single-tablet regimen for the treatment of HIV-1 infection in adults and certain pe…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)